Verdezyne Wins Bloomberg's New Energy Pioneer Award
07/04/16 Filed in:Verdezyne
Picked as One of 10 Game-Changing Companies from Around the World in Recognition of Innovation, Scalability and Momentum
CARLSBAD, Calif. — April 4, 2016 —Verdezyne, Inc., a synthetic biology company producing biobased chemicals, has been named a winner of the Bloomberg New Energy Pioneer Award 2016.
CARLSBAD, Calif. — April 4, 2016 —Verdezyne, Inc., a synthetic biology company producing biobased chemicals, has been named a winner of the Bloomberg New Energy Pioneer Award 2016.
“We are delighted to be recognized by Bloomberg New Energy Finance for our innovation and momentum in the biobased chemicals space,” commented E. William Radany, Ph.D., President and CEO of Verdezyne. “As we continue to execute on our plan of becoming a major provider of such chemicals worldwide, this award serves as a clear affirmation of our progress.”
Verdezyne was chosen by an independent panel of industry experts, assisted by Bloomberg analysts and technology experts, from a large pool of applicants from around the world. Candidates were assessed against three criteria: potential scale, innovation and momentum.
Michael Wilshire, selection committee chair and head of analysis and transformation at Bloomberg New Energy Finance, said: “This year, we were impressed by the very strong set of candidates we received for the New Energy Pioneers program, and the range of activities that they cover – including solar, wind, storage, transport, bioenergy, energy smart technologies and machine learning.”
The 10 winners will be recognized on stage today at the ninth annual Bloomberg New Energy Finance Summit, at the Grand Hyatt New York.
Wilshire continued, “We were delighted to see the breadth of innovation that is happening in the industry and struck by the impact that those organizations could have on the energy system of the future. We are as always very grateful to our group of external judges on the selection committee who had the challenging task of narrowing the field of entries to a final set of 10 winners.”
About Verdezyne Verdezyne is a synthetic biology company offering biobased chemicals developed using proprietary metabolic pathway engineering tools. The company’s first product, BIOLON™ DDDA, earned the USDA Certified Biobased Product label, and is available worldwide. Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby.
For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.
About The Future of Energy Summit The Future of Energy Summit is powered by Bloomberg New Energy Finance‘s news, data and analysis. Bloomberg New Energy Finance provides unique analysis, tools and data for decision makers driving change in the energy system. With unrivalled depth and breadth, BNEF helps clients stay on top of Since its inception in 2008, the Future of Energy Summit has featured a unique convergence of the old and the new – traditional players and advanced-energy leaders . It continues to create an environment for making new connections, and serves as a forum to discuss the critical energy issues of today and the next decade. For more information, please visit http://about.bnef.com/summit/
Verdezyne was chosen by an independent panel of industry experts, assisted by Bloomberg analysts and technology experts, from a large pool of applicants from around the world. Candidates were assessed against three criteria: potential scale, innovation and momentum.
Michael Wilshire, selection committee chair and head of analysis and transformation at Bloomberg New Energy Finance, said: “This year, we were impressed by the very strong set of candidates we received for the New Energy Pioneers program, and the range of activities that they cover – including solar, wind, storage, transport, bioenergy, energy smart technologies and machine learning.”
The 10 winners will be recognized on stage today at the ninth annual Bloomberg New Energy Finance Summit, at the Grand Hyatt New York.
Wilshire continued, “We were delighted to see the breadth of innovation that is happening in the industry and struck by the impact that those organizations could have on the energy system of the future. We are as always very grateful to our group of external judges on the selection committee who had the challenging task of narrowing the field of entries to a final set of 10 winners.”
About Verdezyne Verdezyne is a synthetic biology company offering biobased chemicals developed using proprietary metabolic pathway engineering tools. The company’s first product, BIOLON™ DDDA, earned the USDA Certified Biobased Product label, and is available worldwide. Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby.
For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.
About The Future of Energy Summit The Future of Energy Summit is powered by Bloomberg New Energy Finance‘s news, data and analysis. Bloomberg New Energy Finance provides unique analysis, tools and data for decision makers driving change in the energy system. With unrivalled depth and breadth, BNEF helps clients stay on top of Since its inception in 2008, the Future of Energy Summit has featured a unique convergence of the old and the new – traditional players and advanced-energy leaders . It continues to create an environment for making new connections, and serves as a forum to discuss the critical energy issues of today and the next decade. For more information, please visit http://about.bnef.com/summit/